1 Scorsetti M,Leo F,Trama A,et al.Thymoma and thymic carcinomas[J].Crit Rev Oncol Hematol,2016,99(6):332-350. 2 Fukuhara M,Higuchi M,Owada Y,et al.Clinical and pathological aspects of microscopic thymoma with myasthenia gravis and review of published reports[J].J Thorac Dis,2017,9(6):1592-1597. 3 Li JF,Hui BG,Li X,et al.Video-assisted thoracic surgery for thymoma:long-term follow-up results and prognostic factors-single-center experience of 150 cases[J].J Thorac Dis,2018,10(1):291-297. 4 Wang GW,Tao T,Li CK,et al.Comparison between thoracoscopic and open approaches in thymoma resection[J].J Thorac Dis,2019,11(10):4159-4168. 5 Qi G,Liu P,Dong H,et al.Metastatic thymoma-associated myasthenia gravis:favorable response to steroid pulse therapy plus immunosuppressive agent[J].Med Sci Monit,2017,23:1217-1223. 6 李月敏,李杨,樊文梅,等.胸腺瘤与自身免疫性疾病的关系[J].解放军医学杂志,2014,39(8):669-672. 7 Hsiao SY,Chang KY,Chang JY,et al.Nephrotic syndrome associated with thymoma[J].Cancer Res Pract,2014,1(3):233-240. 8 Travis WD,Brambilla E,Müller-Hermelink HK,et al.WHO classification of pathology and genetics of tumours of the lung,pleura,thymus and heart,3th edition[J].Lyon:International Agency for Research on Cancer,2004:105-144. 9 Masaoka A,Monden Y,Nakahara K,et al.Follow-up study of thymomas with special reference to their clinical stages[J].Cancer,1981,48(11):2485-2492. 10 Weissferdt A,Moran CA.Staging of thymic epithelial neoplasms:Thymoma and thymic carcinoma[J].Pathol Res Pract,2015,211(1):2-11. 11 Sanders DB,Wolfe GI,Benatar M,et al.International consensus guidance for management of myasthenia gravis:executive summary[J].Neurology,2016,87(4):419-425. 12 Lippner EA,Lewis DB,Robinson WH,et al.Paraneoplastic and therapy-related immune complications in thymic malignancies[J].Curr Treat Options Oncol,2019,20(7):62. 13 袁东风,谷志涛,梁光辉,等.胸腺瘤合并重症肌无力患者预后的临床研究[J].中国肺癌杂志,2018,21(1):1-7. 14 Cacho-Díaz B,Salmerón-Moreno K,Lorenzana-Mendoza NA,et al.Myasthenia gravis as a prognostic marker in patients with thymoma[J].J Thorac Dis,2018,10(5):2842-2848. 15 Aydemir B.The effect of myasthenia gravis as a prognostic factor in thymoma treatment[J].North Clin Istanb,2016,3(3):194-200. 16 Zhang Z,Cui Y,Jia R,et al.Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy[J].Oncol Lett,2016,11(6):4177-4182. 17 Margaritora S,Cesario A,Cusumano G,et al.Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery[J].Ann Thorac Surg,2010,89(1):245-252. 18 Aydiner A,Toker A,Sen F,et al.Association of clinical and pathological variables with survival in thymoma[J].Med Oncol,2012,29(3):2221-2228. 19 谷鸿秋,王杨,李卫.生存曲线校正方法[J].中华流行病学杂志,2014,35(1):97-99. 20 Kocer B,Kaplan T,Günal N,et al.Long-term survival after R0 resection of thymoma[J].Asian Cardiovasc Thorac Ann,2018,26(6):461-466. 21 Tseng YC,Tseng YH,Kao HL,et al.Long term oncological outcome of thymoma and thymic carcinoma-an analysis of 235 cases from a single institution[J].PLoS One,2017,12(6):e0179527. 22 Zhao Y,Shi J,Fan L,et al.Surgical treatment of thymoma:an 11-year experience with 761 patients[J].Eur J Cardiothorac Surg,2016,49(4):1144-1149. 23 Yuan ZY,Gao SG,Mu JW,et al.Long-term outcomes of 307 patients after complete thymoma resection[J].Chin J Cancer,2017,36(1):1-9. |